BioCentury | Apr 29, 2013
Company News

BioCrea, Dresden University of Technology deal

...genetic mutations, which BioCrea said have recently shown links to the familial form of ALS. BioCrea...
...cell lines for use in identifying compounds for ALS. The partners declined to disclose details. BioCrea GmbH...
BioCentury | Mar 5, 2012
Company News

biocrea, Boehringer Ingelheim deal

...Boehringer acquired biocrea's phosphodiesterase-2 (PDE-2) program. The program's lead compound is BCA909 , a PDE-2 inhibitor...
...cognitive impairment and Alzheimer's disease (AD). biocrea will receive an undisclosed cash payment from Boehringer. biocrea...
...preclinical testing for Huntington's disease (HD) and a dual PDE-2/PDE-10 inhibitor in discovery for schizophrenia. biocrea...
BioCentury | Sep 19, 2011
Clinical News

biocrea preclinical data

...not induce tolerance. Data were presented at the European College of Neuropharmacology meeting in Paris. biocrea GmbH...
BioCentury | Jan 3, 2011
Company News

biocrea management update

biocrea GmbH , Radebeul, Germany Business: Neurology Hired: Martin Gunthorpe as CSO, formerly head of electrophysiology and project leader in the Neurosciences Centre of Excellence for Drug Discovery at GlaxoSmithKline plc ; Viktor Viehweg as CFO,...
BioCentury | Jan 3, 2011
Company News

Biotie autoimmune, pulmonary news

...clinical development of ronomilast and BTT-1023 . Biotie spun-off its Radebeul, Germany, site into newco, biocrea GmbH...
BioCentury | Nov 15, 2010
Company News

Biotie neurology news

...Biotie spun out newco biocrea GmbH (Radebeul, Germany) to focus on developing phosphodiesterase (PDE) inhibitors to treat...
...Radebeul, Germany) to focus on developing phosphodiesterase (PDE) inhibitors to treat CNS disorders. Biotie granted biocrea...
BioCentury | Nov 1, 2010
Company News

Biotie autoimmune, pulmonary news

...As part of the restructuring, Biotie will spin-off its Radebeul, Germany, site into newco, biocrea GmbH...
...become managing director of biocrea. Biotie will invest up to €4.8 million ($6.7 million) in biocrea...
BioCentury | Oct 30, 2010
Company News

Biotie planning restructuring, spinout

...of the restructuring, Biotie will spin off its Radebeul, Germany, site into a new company, biocrea GmbH...
Items per page:
1 - 8 of 8
BioCentury | Apr 29, 2013
Company News

BioCrea, Dresden University of Technology deal

...genetic mutations, which BioCrea said have recently shown links to the familial form of ALS. BioCrea...
...cell lines for use in identifying compounds for ALS. The partners declined to disclose details. BioCrea GmbH...
BioCentury | Mar 5, 2012
Company News

biocrea, Boehringer Ingelheim deal

...Boehringer acquired biocrea's phosphodiesterase-2 (PDE-2) program. The program's lead compound is BCA909 , a PDE-2 inhibitor...
...cognitive impairment and Alzheimer's disease (AD). biocrea will receive an undisclosed cash payment from Boehringer. biocrea...
...preclinical testing for Huntington's disease (HD) and a dual PDE-2/PDE-10 inhibitor in discovery for schizophrenia. biocrea...
BioCentury | Sep 19, 2011
Clinical News

biocrea preclinical data

...not induce tolerance. Data were presented at the European College of Neuropharmacology meeting in Paris. biocrea GmbH...
BioCentury | Jan 3, 2011
Company News

biocrea management update

biocrea GmbH , Radebeul, Germany Business: Neurology Hired: Martin Gunthorpe as CSO, formerly head of electrophysiology and project leader in the Neurosciences Centre of Excellence for Drug Discovery at GlaxoSmithKline plc ; Viktor Viehweg as CFO,...
BioCentury | Jan 3, 2011
Company News

Biotie autoimmune, pulmonary news

...clinical development of ronomilast and BTT-1023 . Biotie spun-off its Radebeul, Germany, site into newco, biocrea GmbH...
BioCentury | Nov 15, 2010
Company News

Biotie neurology news

...Biotie spun out newco biocrea GmbH (Radebeul, Germany) to focus on developing phosphodiesterase (PDE) inhibitors to treat...
...Radebeul, Germany) to focus on developing phosphodiesterase (PDE) inhibitors to treat CNS disorders. Biotie granted biocrea...
BioCentury | Nov 1, 2010
Company News

Biotie autoimmune, pulmonary news

...As part of the restructuring, Biotie will spin-off its Radebeul, Germany, site into newco, biocrea GmbH...
...become managing director of biocrea. Biotie will invest up to €4.8 million ($6.7 million) in biocrea...
BioCentury | Oct 30, 2010
Company News

Biotie planning restructuring, spinout

...of the restructuring, Biotie will spin off its Radebeul, Germany, site into a new company, biocrea GmbH...
Items per page:
1 - 8 of 8